Review
Published on 22 Nov 2024
A review focuses on a neglected and controversial component of SCI: myelin debris
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1436031
Type at least 3 characters
1,298 articles
Articles
Original Research
Accepted on 21 Nov 2024
Application and interpretation of core elements of the 2015 NMOSD diagnostic criteria in routine clinical practice
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1515481
Original Research
Accepted on 20 Nov 2024
Review of Clinical and Imaging Findings in Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy to Aid in Early Diagnosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1466847
Original Research
Published on 20 Nov 2024
The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1443940
- 234 views
Original Research
Published on 19 Nov 2024
Stimulation of microneedles alleviates pathology of Parkinson’s disease in mice by regulating the CD4+/CD8+ cells from the periphery to the brain
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1454102
- 195 views
Review
Accepted on 18 Nov 2024
Temporal changes of spinal microglia in murine models of neuropathic pain: a scoping review
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1460072
Case Report
Accepted on 18 Nov 2024
Chronic inflammatory demyelinating polyradiculoneuropathy with severe central nervous system demyelination: a clinicopathological study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1477615
Original Research
Accepted on 18 Nov 2024
Frequency, characteristics, and immunological accompaniments of ataxia in anti-NMDAR antibody-associated encephalitis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1500904
Case Report
Published on 18 Nov 2024
Telitacicept in combination with B-cell depletion therapy in MuSK antibody-positive myasthenia gravis: a case report and literature review
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1456822
- 192 views
Original Research
Accepted on 14 Nov 2024
Lysate of Parabacteroides distasonis prevents severe forms of experimental autoimmune encephalomyelitis by modulating the priming of T cell response
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1475126
Original Research
Published on 14 Nov 2024
Global perspectives on the contribution of B cells to multiple sclerosis: an in-depth examination and evaluation
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1442694
- 283 views
Original Research
Accepted on 13 Nov 2024
Research hotspots and trends for Duchenne muscular dystrophy: A machine learning bibliometric analysis from 2004 to 2023
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1429609
Original Research
Published on 12 Nov 2024
Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1480676
- 389 views
Original Research
Accepted on 08 Nov 2024
In-depth analysis of serum antibodies against Epstein-Barr virus (EBV) lifecycle proteins and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1487523
- 117 views
Case Report
Published on 07 Nov 2024
Case report: The case report of ofatumumab, a fully human anti-CD20 monoclonal antibody, in the treatment of KLHL11 encephalitis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1456840
- 174 views
Case Report
Published on 06 Nov 2024
Case report: Infectious mononucleosis with bilateral retinal haemorrhages under myelin oligodendrocyte glycoprotein antibody-associated disease
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1480134
- 244 views